Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
McKinsey
Chubb
US Department of Justice
AstraZeneca
Johnson and Johnson
Covington
Colorcon
Harvard Business School

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017673

« Back to Dashboard

NDA 017673 describes AMINOSYN 8.5% W/ ELECTROLYTES, which is a drug marketed by Icu Medical Inc and is included in one NDA. It is available from one supplier. Additional details are available on the AMINOSYN 8.5% W/ ELECTROLYTES profile page.

The generic ingredient in AMINOSYN 8.5% W/ ELECTROLYTES is amino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride. There are three hundred and forty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride profile page.
Summary for 017673
Suppliers and Packaging for NDA: 017673
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMINOSYN 10% amino acids INJECTABLE;INJECTION 017673 NDA Hospira, Inc. 0409-4187 N 0409-4187-03
AMINOSYN 10% (PH6) amino acids INJECTABLE;INJECTION 017673 NDA Hospira, Inc. 0409-4187 N 0409-4187-03

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5% (5GM/100ML)
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength7% (7GM/100ML)
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10% (10GM/100ML)
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Dow
Cantor Fitzgerald
Julphar
Covington
Harvard Business School
Medtronic
Fuji
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.